Dueling neural networks. Artificial embryos. AI in the cloud. Welcome to our annual list of the 10 technology advances we think will shape the way we work and live now and for years to come.
Kenneth Frazier, the CEO of the pharmaceutical company known as MSD outside of North America, discusses his upbringing and how it influences his leadership as chief executive. He is one of the few African-American CEOs in the Fortune 500, and shot to prominence after resigning from a council advising the Trump White House. Frazier discusses the importance of values in leadership and how Merck thinks about R&D and drug prices.
It’s great to start with a big dream as you contemplate a new business, but finding the money you need takes more than dreaming. As an advisor to young entrepreneurs, I find that many are a bit naïve about how the investment process really works. For example, I just read an otherwise impressive business plan last week from a first-timer who asked for $10 million to get started.
Johns Hopkins students have access to a new funding source designed to ignite innovative ideas that may one day develop into the next great company founded by a university student.
Our region has a vibrant innovation ecosystem that is one of the most important in the United States. Advanced technologies that drive the country’s economy are nurtured here and further developed and deployed by our highly talented workforce and entrepreneurs. People often don’t see the scale and depth of our innovation and entrepreneurship activity because they focus on the wrong metric.
Shares of Gaithersburg-based Novavax Inc. have spiked again, jumping by 18 percent during Friday trading, as the company is increasingly considered a promising acquisition target.
The big headline out of the health care M&A world today is Swiss pharmaceutical giant Roche’s $1.9 billion acquisition of Flatiron Health, the Alphabet-backed, cancer-focused digital health analytics upstart that’s attempting to use real world patient information and big data to spur better oncology R&D.
Congress recently enacted the most significant overhaul to the U.S. Internal Revenue Code (the Code) in decades. The legislation, commonly known as the Tax Cuts and Jobs Act (the Act), includes a number of changes to the Code that apply to corporate and pass-through businesses. This Q&A summarizes the key tax and employee benefits changes in the Act that impact domestic emerging growth enterprises and start-ups. For additional information on the Act, see our prior alerts: Congress Passes Tax Cuts and Jobs Act and U.S. House and Senate Pass Reconciled Tax Cuts and Jobs Act.
Seventy-five years ago, Silicon Valley was fruit orchids and Detroit was dominating the most exciting industry in the nation. “Things can change,” Steve Case said of the tidal shifts of the U.S. innovation economy.
Roche Holding will buy Flatiron Health and its cancer-focused medical records technology for $1.9 billion, as drugmakers increasingly mine data to develop new oncology treatments.